Ftse Mib
34.890,64
0,46%
DAX
20.404,67
-0,04%
S&P 500
6.084,19
0,82%
NASDAQ
20.034,89
0,00%
Bitcoin
100.892,60
-0,30%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GeoVax Labs Inc (GOVX) GeoVax Labs Inc (GOVX) Notizie

GeoVax Labs Inc

GOVX
2,44
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:24:21
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/12/202415:00GLOBEGeoVax Receives Notice of Allowance For Cancer Vaccine..
26/11/202415:00GLOBEGeoVax to Present at the Noble Capital Markets Twentieth..
19/11/202415:00GLOBEGeoVax Announces Positive Interim Data Review for Phase 2..
12/11/202422:00GLOBEGeoVax Reports Third Quarter 2024 Financial Results and..
05/11/202415:00GLOBEGeoVax to Report Third Quarter 2024 Financial Results and..
02/10/202415:00GLOBEGeoVax to Participate in the 3rd Annual ROTH Healthcare..
03/9/202415:00GLOBEGeoVax to Participate in Upcoming Investor Conferences in..
30/8/202422:15EDGAR2Form 8-K - Current report
30/8/202415:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/8/202402:59GLOBEGeoVax to Raise Approximately $5.0 Million of Gross Proceeds..
21/8/202422:19EDGAR2Form 8-K - Current report
21/8/202415:22EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/8/202415:00GLOBERegistration is Now Open for Tribe Public’s Webinar Event..
20/8/202413:45GLOBEGeoVax to Raise Approximately $8.5 Million of Gross Proceeds..
14/8/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/8/202414:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202415:00GLOBEGeoVax Appoints Teresa Lambe, Acclaimed Professor of..
07/8/202422:05EDGAR2Form 8-K - Current report
06/8/202423:17EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/8/202423:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/8/202423:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/8/202423:12EDGAR2Form S-1 - General form for registration of securities under..
06/8/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:00GLOBEGeoVax Reports Second Quarter 2024 Financial Results and..
01/8/202422:12EDGAR2Form DEF 14A - Other definitive proxy statements
31/7/202416:15GLOBEUpdate: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer..
31/7/202415:00GLOBEGeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy..
30/7/202415:00GLOBEGeoVax to Report Second Quarter 2024 Financial Results and..
22/7/202422:21EDGAR2Form PRE 14A - Other preliminary proxy statements
12/7/202422:02EDGAR2Form 8-K - Current report
12/7/202416:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/4/202418:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
28/3/202414:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
12/3/202414:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
11/3/202421:13EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
06/3/202415:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
01/3/202422:08EDGAR2Form S-3 - Registration statement under Securities Act of..
29/2/202422:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
Apertura: Min: Max:
Chiusura: 2,44

La tua Cronologia

NASDAQ
GOVX
GeoVax Labs
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network